Changes With Lanthanum Carbonate, Calcium Acetate, and Phosphorus Restriction in CKD: A Randomized Controlled Trial.

about

Changes With Lanthanum Carbonate, Calcium Acetate, and Phosphorus Restriction in CKD: A Randomized Controlled Trial.

Item

http://www.wikidata.org/entity/Q55509854

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Changes With Lanthanum Carbona ...... A Randomized Controlled Trial.

@en

Changes With Lanthanum Carbona ...... A Randomized Controlled Trial.

@nl

type

Item

label

Changes With Lanthanum Carbona ...... A Randomized Controlled Trial.

@en

Changes With Lanthanum Carbona ...... A Randomized Controlled Trial.

@nl

altLabel

Changes With Lanthanum Carbona ...... A Randomized Controlled Trial

@en

prefLabel

Changes With Lanthanum Carbona ...... A Randomized Controlled Trial.

@en

Changes With Lanthanum Carbona ...... A Randomized Controlled Trial.

@nl

P1476

Changes With Lanthanum Carbona ...... A Randomized Controlled Trial.

@en

P2093

Adnan Naseer

http://www.w3.org/2001/XMLSchema#string

Angela Wallick

http://www.w3.org/2001/XMLSchema#string

Barry M. Wall

http://www.w3.org/2001/XMLSchema#string

Geeta Gyamlani

http://www.w3.org/2001/XMLSchema#string

Jun Ling Lu

http://www.w3.org/2001/XMLSchema#string

L. Darryl Quarles

http://www.w3.org/2001/XMLSchema#string

Nabil Jarmukli

http://www.w3.org/2001/XMLSchema#string

Zhongji Han

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphate regulation of vascular smooth muscle cell calcification

Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

Control of phosphate excretion in uremic man.

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

Phosphorus binders and survival on hemodialysis.

BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells.

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.

Effects of phosphate binders in moderate CKD

The assessment of endothelial function: from research into clinical practice.

P304

897-904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EKIR.2018.03.011

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fridtjof Thomas

Csaba P. Kovesdy

P577

2018-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29989014

http://www.w3.org/2001/XMLSchema#string

P921

nephrology

P932

6035139

http://www.w3.org/2001/XMLSchema#string